Copyright © 2009 Maria Baou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. P. J. Blackshear, R. S. Phillips, S. Ghosh, S. V. B. Ramos, E. K. Richfield, and W. S. Lai, “Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the tristetraprolin family of CCCH tandem zinc finger proteins,” Biology of Reproduction, vol. 73, no. 2, pp. 297–307, 2005. View at Publisher · View at Google Scholar · View at PubMed
2. Q. Ma, D. Wadleigh, T. Chi, and H. Herschman, “The Drosophila TIS11 homologue encodes a developmentally controlled gene,” Oncogene, vol. 9, no. 11, pp. 3329–3334, 1994.
3. Q. Ma and H. R. Herschman, “The yeast homologue YTIS11, of the mammalian TIS11 gene family is a non-essential, glucose repressible gene,” Oncogene, vol. 10, no. 3, pp. 487–494, 1995.
4. M. J. Thompson, W. S. Lai, G. A. Taylor, and P. J. Blackshear, “Cloning and characterization of two yeast genes encoding members of the CCCH class of zinc finger proteins: zinc finger-mediated impairment of cell growth,” Gene, vol. 174, no. 2, pp. 225–233, 1996. View at Publisher · View at Google Scholar
5. P. J. Blackshear, “Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover,” Biochemical Society Transactions, vol. 30, no. 6, pp. 945–952, 2002. View at Publisher · View at Google Scholar
6. C. J. Wilusz, M. Wormington, and S. W. Peltz, “The cap-to-tail guide to mRNA turnover,” Nature Reviews Molecular Cell Biology, vol. 2, no. 4, pp. 237–246, 2001. View at Publisher · View at Google Scholar · View at PubMed
7. T. Bakheet, B. R. G. Williams, and K. S. A. Khabar, “ARED 2.0: an update of AU-rich element mRNA database,” Nucleic Acids Research, vol. 31, no. 1, pp. 421–423, 2003. View at Publisher · View at Google Scholar
8. E. Carballo, W. S. Lai, and P. J. Blackshear, “Feedback inhibition of macrophage tumor necrosis factor-$\alpha$ production by tristetraprolin,” Science, vol. 281, no. 5379, pp. 1001–1005, 1998.
9. M. T. Worthington, J. W. Pelo, M. A. Sachedina, J. L. Applegate, K. O. Arseneau, and T. T. Pizarro, “RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein,” The Journal of Biological Chemistry, vol. 277, no. 50, pp. 48558–48564, 2002. View at Publisher · View at Google Scholar · View at PubMed
10. P. J. Blackshear, W. S. Lai, E. A. Kennington, et al., “Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing RNA substrates,” The Journal of Biological Chemistry, vol. 278, no. 22, pp. 19947–19955, 2003. View at Publisher · View at Google Scholar · View at PubMed
11. B. Y. Brewer, J. Malicka, P. J. Blackshear, and G. M. Wilson, “RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite nature of AU-rich mRNA-destabilizing motifs,” The Journal of Biological Chemistry, vol. 279, no. 27, pp. 27870–27877, 2004. View at Publisher · View at Google Scholar · View at PubMed
12. W. S. Lai, D. M. Carrick, and P. J. Blackshear, “Influence of nonameric AU-rich tristetraprolin-binding sites on mRNA deadenylation and turnover,” The Journal of Biological Chemistry, vol. 280, no. 40, pp. 34365–34377, 2005. View at Publisher · View at Google Scholar · View at PubMed
13. S. A. Bustin, X.-F. Nie, R. C. Barnard, et al., “Cloning and characterization of ERF-1, a human member of the Tis11 family of early-response genes,” DNA and Cell Biology, vol. 13, no. 5, pp. 449–459, 1994.
14. S. A. Brooks, J. E. Connoly, and W. F. C. Rigby, “The role of mRNA turnover in the regulation of tritetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway,” The Journal of Immunology, vol. 172, no. 12, pp. 7263–7271, 2004.
15. E. Carballo, W. S. Lai, and P. J. Blackshear, “Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability,” Blood, vol. 95, no. 6, pp. 1891–1899, 2000.
16. G. Stoecklin, X.-F. Ming, R. Looser, and C. Moroni, “Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway,” Molecular and Cellular Biology, vol. 20, no. 11, pp. 3753–3763, 2000. View at Publisher · View at Google Scholar
17. G. Stoecklin, P. Stoeckle, M. Lu, O. Muehlemann, and C. Moroni, “Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements,” RNA, vol. 7, no. 11, pp. 1578–1588, 2001.
18. H. Sawaoka, D. A. Dixon, J. A. Oates, and O. Boutaud, “Tristetraprolin binds to the $3^{\prime }$-untranslated region of cyclooxygenase-2 mRNA: a polyadenylation variant in a cancer cell line lacks the binding site,” The Journal of Biological Chemistry, vol. 278, no. 16, pp. 13928–13935, 2003. View at Publisher · View at Google Scholar · View at PubMed
19. H. Yu, S. Stasinopoulos, P. Leedman, and R. L. Medcalf, “Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin,” The Journal of Biological Chemistry, vol. 278, no. 16, pp. 13912–13918, 2003. View at Publisher · View at Google Scholar · View at PubMed
20. P. Briata, C. Ilengo, G. Corte, et al., “The Wnt/$\beta$-catenin$\to$Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs,” Molecular Cell, vol. 12, no. 5, pp. 1201–1211, 2003. View at Publisher · View at Google Scholar
21. R. L. Ogilvie, M. Abelson, H. H. Hau, I. Vlasova, P. J. Blackshear, and P. R. Bohjanen, “Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay,” The Journal of Immunology, vol. 174, no. 2, pp. 953–961, 2005.
22. S. I. Gringhuis, J. J. García-Vallejo, B. van Het Hof, and W. van Dijk, “Convergent actions of I$\kappa$B kinase $\beta$ and protein kinase C $\delta$ modulate mRNA stability through phosphorylation of 14-3-3 $\beta$ complexed with tristetraprolin,” Molecular and Cellular Biology, vol. 25, no. 15, pp. 6454–6463, 2005. View at Publisher · View at Google Scholar · View at PubMed
23. U. Jalonen, R. Nieminen, K. Vuolteenaho, H. Kankaanranta, and E. Moilanen, “Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3$\alpha$ synthesis in activated macrophages,” Mediators of Inflammation, vol. 2006, Article ID 40691, 8 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
24. I. Sauer, B. Schaljo, C. Vogl, et al., “Interferons limit inflammatory responses by induction of tristetraprolin,” Blood, vol. 107, no. 12, pp. 4790–4797, 2006. View at Publisher · View at Google Scholar · View at PubMed
25. M. Marderosian, A. Sharma, A. P. Funk, et al., “Tristetraprolin regulates cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling,” Oncogene, vol. 25, no. 47, pp. 6277–6290, 2006. View at Publisher · View at Google Scholar · View at PubMed
26. W. D. Patino, J.-G. Kang, S. Matoba, O. Y. Mian, B. R. Gochuico, and P. M. Hwang, “Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin,” Circulation Research, vol. 98, no. 10, pp. 1282–1289, 2006. View at Publisher · View at Google Scholar · View at PubMed
27. W. S. Lai, J. S. Parker, S. F. Grissom, D. J. Stumpo, and P. J. Blackshear, “Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts,” Molecular and Cellular Biology, vol. 26, no. 24, pp. 9196–9208, 2006. View at Publisher · View at Google Scholar · View at PubMed
28. D. Frasca, A. M. Landin, J. P. Alvarez, P. J. Blackshear, R. L. Riley, and B. B. Blomberg, “Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA,” The Journal of Immunology, vol. 179, no. 2, pp. 918–927, 2007.
29. K. Essafi-Benkhadir, C. Onesto, E. Stebe, C. Moroni, and G. Pagès, “Tristetraprolin inhibits ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation,” Molecular Biology of the Cell, vol. 18, no. 11, pp. 4648–4658, 2007. View at Publisher · View at Google Scholar · View at PubMed
30. G. Stoecklin, S. A. Tenenbaum, T. Mayo, et al., “Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin,” The Journal of Biological Chemistry, vol. 283, no. 17, pp. 11689–11699, 2008. View at Publisher · View at Google Scholar · View at PubMed
31. T. J. Horner, W. S. Lai, D. J. Stumpo, and P. J. Blackshear, “Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin,” Molecular and Cellular Biology, vol. 29, no. 8, pp. 1999–2010, 2009. View at Publisher · View at Google Scholar · View at PubMed
32. W. S. Lai, E. Carballo, J. M. Thorn, E. A. Kennington, and P. J. Blackshear, “Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to AU-rich elements and destabilization of mRNA,” The Journal of Biological Chemistry, vol. 275, no. 23, pp. 17827–17837, 2000. View at Publisher · View at Google Scholar · View at PubMed
33. W. S. Lai and P. J. Blackshear, “Interactions of CCCH zinc finger proteins with mRNA. Tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail,” The Journal of Biological Chemistry, vol. 276, no. 25, pp. 23144–23154, 2001. View at Publisher · View at Google Scholar · View at PubMed
34. G. Stoecklin, M. Colombi, I. Raineri, et al., “Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover,” The EMBO Journal, vol. 21, no. 17, pp. 4709–4718, 2002. View at Publisher · View at Google Scholar
35. D. Ciais, N. Cherradi, S. Bailly, et al., “Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b,” Oncogene, vol. 23, no. 53, pp. 8673–8680, 2004. View at Publisher · View at Google Scholar · View at PubMed
36. S. K. Lee, S. B. Kim, J. S. Kim, et al., “Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines,” International Journal of Cancer, vol. 117, no. 1, pp. 32–40, 2005. View at Publisher · View at Google Scholar · View at PubMed
37. S. E. Bell, M. J. Sanchez, O. Spasic-Boskovic, et al., “The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression,” Developmental Dynamics, vol. 235, no. 11, pp. 3144–3155, 2006. View at Publisher · View at Google Scholar · View at PubMed
38. H. Duan, N. Cherradi, J.-J. Feige, and C. Jefcoate, “cAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11b,” Molecular Endocrinology, vol. 23, no. 4, pp. 497–509, 2009. View at Publisher · View at Google Scholar · View at PubMed
39. W. S. Lai, E. A. Kennington, and P. J. Blackshear, “Interactions of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs,” The Journal of Biological Chemistry, vol. 277, no. 11, pp. 9606–9613, 2002. View at Publisher · View at Google Scholar · View at PubMed
40. W. S. Lai, E. A. Kennington, and P. J. Blackshear, “Tristetraprolin and its family members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease,” Molecular and Cellular Biology, vol. 23, no. 11, pp. 3798–3812, 2003. View at Publisher · View at Google Scholar
41. J. Lykke-Andersen and E. Wagner, “Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1,” Genes and Development, vol. 19, no. 3, pp. 351–361, 2005. View at Publisher · View at Google Scholar · View at PubMed
42. M. Fenger-Grøn, C. Fillman, B. Norrild, and J. Lykke-Andersen, “Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping,” Molecular Cell, vol. 20, no. 6, pp. 905–915, 2005. View at Publisher · View at Google Scholar · View at PubMed
43. C.-Y. Chen, R. Gherzi, S.-E. Ong, et al., “AU binding proteins recruit the exosome to degrade ARE-containing mRNAs,” Cell, vol. 107, no. 4, pp. 451–464, 2001. View at Publisher · View at Google Scholar
44. G. A. Taylor, E. Carballo, D. M. Lee, et al., “A pathogenetic role for TNF$\alpha$ in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency,” Immunity, vol. 4, no. 5, pp. 445–454, 1996. View at Publisher · View at Google Scholar
45. K. Suzuki, H. Nakajima, K. Ikeda, et al., “IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-$\alpha$ production in mast cells,” Journal of Experimental Medicine, vol. 198, no. 11, pp. 1717–1727, 2003. View at Publisher · View at Google Scholar · View at PubMed
46. J.-C. Twizere, V. Kruys, L. Lefèbvre, et al., “Interaction of retroviral tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-$\alpha$ expression,” Journal of the National Cancer Institute, vol. 95, no. 24, pp. 1846–1859, 2003.
47. W. F. C. Rigby, K. Roy, J. Collins, et al., “Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function,” The Journal of Immunology, vol. 174, no. 12, pp. 7883–7893, 2005.
48. Q. Jing, S. Huang, S. Guth, et al., “Involvement of microRNA in AU-Rich element-mediated mRNA instability,” Cell, vol. 120, no. 5, pp. 623–634, 2005. View at Publisher · View at Google Scholar · View at PubMed
49. S. Dorner, L. Lum, M. Kim, R. Paro, P. A. Beachy, and R. Green, “A genomewide screen for components of the RNAi pathway in Drosophila cultured cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 32, pp. 11880–11885, 2006. View at Publisher · View at Google Scholar · View at PubMed
50. A. J. Asirvatham, C. J. Gregorie, Z. Hu, W. J. Magner, and T. B. Tomasi, “MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components,” Molecular Immunology, vol. 45, no. 7, pp. 1995–2006, 2008. View at Publisher · View at Google Scholar · View at PubMed
51. R. N. DuBois, M. W. McLane, K. Ryder, L. F. Lau, and D. Nathans, “A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence,” The Journal of Biological Chemistry, vol. 265, no. 31, pp. 19185–19191, 1990.
52. G. A. Taylor, W. S. Lai, R. J. Oakey, et al., “The human TTP protein: sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes,” Nucleic Acids Research, vol. 19, no. 12, p. 3454, 1991.
53. B. C. Varnum, R. W. Lim, V. P. Sukhatme, and H. R. Herschman, “Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate,” Oncogene, vol. 4, no. 1, pp. 119–120, 1989.
54. J. J. Murphy and J. D. Norton, “Cell-type-specific early response gene expression during plasmacytoid differentiation of human B lymphocytic leukemia cells,” Biochimica et Biophysica Acta, vol. 1049, no. 3, pp. 261–271, 1990. View at Publisher · View at Google Scholar
55. Z.-Q. Ning, J. D. Norton, J. Li, and J. J. Murphy, “Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36,” European Journal of Immunology, vol. 26, no. 10, pp. 2356–2363, 1996. View at Publisher · View at Google Scholar · View at PubMed
56. X.-F. Nie, K. N. Maclean, V. Kumar, I. A. McKay, and S. A. Bustin, “ERF-2, the human homologue of the murine TIS11d early response gene,” Gene, vol. 152, no. 2, pp. 285–286, 1995. View at Publisher · View at Google Scholar
57. P. J. Blackshear, R. S. Phillips, J. Vazquez-Matias, and H. Mohrenweiser, “Polymorphisms in the genes encoding members of the tristetraprolin family of human tandem CCCH zinc finger proteins,” Progress in Nucleic Acid Research and Molecular Biology, vol. 75, pp. 43–68, 2003. View at Publisher · View at Google Scholar
58. D. M. Carrick, P. Chulada, R. Donn, et al., “Genetic variations in ZFP36 and their possible relationship to autoimmune diseases,” Journal of Autoimmunity, vol. 26, no. 3, pp. 182–196, 2006. View at Publisher · View at Google Scholar · View at PubMed
59. D. J. Stumpo, N. A. Byrd, R. S. Phillips, et al., “Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the tristetraprolin family,” Molecular and Cellular Biology, vol. 24, no. 14, pp. 6445–6455, 2004. View at Publisher · View at Google Scholar · View at PubMed
60. S. B. V. Ramos, D. J. Stumpo, E. A. Kennington, et al., “The CCCH tandem zinc-finger protein Zfp36l2 is crucial for female fertility and early embryonic development,” Development, vol. 131, no. 19, pp. 4883–4893, 2004. View at Publisher · View at Google Scholar · View at PubMed
61. H. Cao, J. S. Tuttle, and P. J. Blackshear, “Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein,” The Journal of Biological Chemistry, vol. 279, no. 20, pp. 21489–21499, 2004. View at Publisher · View at Google Scholar · View at PubMed
62. H. Shimada, H. Ichikawa, S. Nakamura, et al., “Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF,” Blood, vol. 96, no. 2, pp. 655–663, 2000.
63. T. Ino, H. Yasui, M. Hirano, and Y. Kurosawa, “Identification of a member of the TIS11 early response gene family at the insertion point of a DNA fragment containing a gene for the T-cell receptor $\beta$ chain in an acute T-cell leukemia,” Oncogene, vol. 11, no. 12, pp. 2705–2710, 1995.
64. B. T. Amann, M. T. Worthington, and J. M. Berg, “A Cys3His zinc-binding domain from Nup475/tristetraprolin: a novel fold with a disklike structure,” Biochemistry, vol. 42, no. 1, pp. 217–221, 2003. View at Publisher · View at Google Scholar · View at PubMed
65. B. P. Hudson, M. A. Martinez-Yamout, H. J. Dyson, and P. E. Wright, “Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d,” Nature Structural and Molecular Biology, vol. 11, no. 3, pp. 257–264, 2004. View at Publisher · View at Google Scholar · View at PubMed
66. W. S. Lai, D. J. Stumpo, and P. J. Blackshear, “Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein,” The Journal of Biological Chemistry, vol. 265, no. 27, pp. 16556–16563, 1990.
67. A. N. Corps and K. D. Brown, “Insulin and insulin-like growth factor I stimulate expression of the primary response gene cMG1/TIS11b by a wortmannin-sensitive pathway in RIE-1 cells,” FEBS Letters, vol. 368, no. 1, pp. 160–164, 1995. View at Publisher · View at Google Scholar
68. K. R. Mahtani, M. Brook, J. L. E. Dean, G. Sully, J. Saklatvala, and A. R. Clark, “Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability,” Molecular and Cellular Biology, vol. 21, no. 19, pp. 6461–6469, 2001. View at Publisher · View at Google Scholar
69. C. R. Tchen, M. Brook, J. Saklatvala, and A. R. Clark, “The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself,” The Journal of Biological Chemistry, vol. 279, no. 31, pp. 32393–32400, 2004. View at Publisher · View at Google Scholar · View at PubMed
70. A. M. Fairhurst, J. E. Connolly, K. A. Hintz, et al., “Regulation and localization of endogenous human tristetraprolin,” Arthritis Research & Therapy, vol. 5, no. 4, pp. R214–R225, 2003.
71. B. C. Varnum, R. W. Lim, D. A. Kujubu, et al., “Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells,” Molecular and Cellular Biology, vol. 9, no. 8, pp. 3580–3583, 1989.
72. K. Ogawa, F. Chen, Y.-J. Kim, and Y. Chen, “Transcriptional regulation of tristetraprolin by transforming growth factor-$\beta$ in human T cells,” The Journal of Biological Chemistry, vol. 278, no. 32, pp. 30373–30381, 2003. View at Publisher · View at Google Scholar · View at PubMed
73. A. Raghavan, R. L. Robison, J. McNabb, C. R. Miller, D. A. Williams, and P. R. Bohjanen, “HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities,” The Journal of Biological Chemistry, vol. 276, no. 51, pp. 47958–47965, 2001.
74. K. Smoak and J. A. Cidlowski, “Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling,” Molecular and Cellular Biology, vol. 26, no. 23, pp. 9126–9135, 2006. View at Publisher · View at Google Scholar · View at PubMed
75. F. T. Ishmael, X. Fang, M. R. Galdiero, et al., “Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation,” The Journal of Immunology, vol. 180, no. 12, pp. 8342–8353, 2008.
76. Z.-Q. Ning, T. Hirose, R. Deed, J. Newton, J. J. Murphy, and J. D. Norton, “Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro,” Biochemical Journal, vol. 319, part 1, pp. 59–65, 1996.
77. M. Baou, A. Jewell, A. Muthurania, et al., “Involvement of TIS11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells,” Leukemia, vol. 23, pp. 986–989, 2009. View at Publisher · View at Google Scholar · View at PubMed
78. S. Mathas, A. Rickers, K. Bommert, B. Dörken, and M. Y. Mapara, “Anti-CD20-and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways,” Cancer Research, vol. 60, no. 24, pp. 7170–7176, 2000.
79. S. Reppe, O. K. Olstad, E. Rian, V. T. Gautvik, K. M. Gautvik, and R. Jemtland, “Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells,” Biochemical and Biophysical Research Communications, vol. 324, no. 1, pp. 218–223, 2004. View at Publisher · View at Google Scholar · View at PubMed
80. A. M. Chinn, D. Ciais, S. Bailly, E. Chambaz, J. LaMarre, and J.-J. Feige, “Identification of two novel ACTH-responsive genes encoding manganese-dependent superoxide dismutase (SOD2) and the zinc finger protein TIS11b [tetradecanoyl phorbol acetate (TPA)-inducible sequence 11b],” Molecular Endocrinology, vol. 16, no. 6, pp. 1417–1427, 2002. View at Publisher · View at Google Scholar
81. G. A. Taylor, M. J. Thompson, W. S. Lai, and P. J. Blackshear, “Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zinc-finger transcription factor,” Molecular Endocrinology, vol. 10, no. 2, pp. 140–146, 1996. View at Publisher · View at Google Scholar
82. M. Brook, C. R. Tchen, T. Santalucia, et al., “Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways,” Molecular and Cellular Biology, vol. 26, no. 6, pp. 2408–2418, 2006. View at Publisher · View at Google Scholar · View at PubMed
83. G. A. Taylor, M. J. Thompson, W. S. Lai, and P. J. Blackshear, “Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro,” The Journal of Biological Chemistry, vol. 270, no. 22, pp. 13341–13347, 1995. View at Publisher · View at Google Scholar
84. W. Zhu, M. A. Brauchle, F. Di Padova, et al., “Gene suppression by tristetraprolin and release by the p38 pathway,” American Journal of Physiology, vol. 281, no. 2, pp. L499–L508, 2001.
85. C. A. Chrestensen, M. J. Schroeder, J. Shabanowitz, et al., “MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding,” The Journal of Biological Chemistry, vol. 279, no. 11, pp. 10176–10184, 2004. View at Publisher · View at Google Scholar · View at PubMed
86. L. Sun, G. Stoecklin, S. Van Way, et al., “Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-$\alpha$ mRNA,” The Journal of Biological Chemistry, vol. 282, no. 6, pp. 3766–3777, 2007. View at Publisher · View at Google Scholar · View at PubMed
87. E. Hitti, T. Iakovleva, M. Brook, et al., “Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element,” Molecular and Cellular Biology, vol. 26, no. 6, pp. 2399–2407, 2006. View at Publisher · View at Google Scholar · View at PubMed
88. B. A. Johnson, J. R. Stehn, M. B. Yaffe, and T. K. Blackwell, “Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms,” The Journal of Biological Chemistry, vol. 277, no. 20, pp. 18029–18036, 2002. View at Publisher · View at Google Scholar · View at PubMed
89. H. Cao, L. J. Deterding, J. D. Venable, et al., “Identification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis,” Biochemical Journal, vol. 394, no. 1, pp. 285–297, 2006. View at Publisher · View at Google Scholar · View at PubMed
90. S. Maitra, C.-F. Chou, C. A. Luber, K.-Y. Lee, M. Mann, and C.-Y. Chen, “The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2,” RNA, vol. 14, no. 5, pp. 950–959, 2008. View at Publisher · View at Google Scholar · View at PubMed
91. M. Schmidlin, M. Lu, S. A. Leuenberger, et al., “The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B,” The EMBO Journal, vol. 23, no. 24, pp. 4760–4769, 2004. View at Publisher · View at Google Scholar · View at PubMed
92. R. S. Phillips, S. B. V. Ramos, and P. J. Blackshear, “Members of the tristetraprolin family of tandem CCCH zinc finger proteins exhibit CRM1-dependent nucleocytoplasmic shuttling,” The Journal of Biological Chemistry, vol. 277, no. 13, pp. 11606–11613, 2002. View at Publisher · View at Google Scholar · View at PubMed
93. T. Murata, Y. Yoshino, N. Morita, and N. Kaneda, “Identification of nuclear import and export signals within the structure of the zinc finger protein TIS11,” Biochemical and Biophysical Research Communications, vol. 293, no. 4, pp. 1242–1247, 2002. View at Publisher · View at Google Scholar · View at PubMed
94. J. A. Carman and S. G. Nadler, “Direct association of tristetraprolin with the nucleoporin CAN/Nup214,” Biochemical and Biophysical Research Communications, vol. 315, no. 2, pp. 445–449, 2004. View at Publisher · View at Google Scholar · View at PubMed
95. T. Murata, N. Morita, K. Hikita, K. Kiuchi, K. Kiuchi, and N. Kaneda, “Recruitment of mRNA-destabilizing protein TIS11 to stress granules is mediated by its zinc finger domain,” Experimental Cell Research, vol. 303, no. 2, pp. 287–299, 2005. View at Publisher · View at Google Scholar · View at PubMed
96. G. Stoecklin, T. Stubbs, N. Kedersha, et al., “MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay,” The EMBO Journal, vol. 23, no. 6, pp. 1313–1324, 2004. View at Publisher · View at Google Scholar · View at PubMed
97. N. Kedersha, G. Stoecklin, M. Ayodele, et al., “Stress granules and processing bodies are dynamically linked sites of mRNP remodeling,” Journal of Cell Biology, vol. 169, no. 6, pp. 871–884, 2005. View at Publisher · View at Google Scholar · View at PubMed
98. T. M. Franks and J. Lykke-Andersen, “TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements,” Genes and Development, vol. 21, no. 6, pp. 719–735, 2007. View at Publisher · View at Google Scholar · View at PubMed
99. N. Cougot, S. Babajko, and B. Séraphin, “Cytoplasmic foci are sites of mRNA decay in human cells,” Journal of Cell Biology, vol. 165, no. 1, pp. 31–40, 2004. View at Publisher · View at Google Scholar · View at PubMed
100. A. Jakymiw, S. Lian, T. Eystathioy, et al., “Disruption of GW bodies impairs mammalian RNA interference,” Nature Cell Biology, vol. 7, no. 12, pp. 1267–1274, 2005. View at Publisher · View at Google Scholar · View at PubMed
101. B. A. Johnson, M. Geha, and K. T. Blackwell, “Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival,” Oncogene, vol. 19, no. 13, pp. 1657–1664, 2000.
102. B. A. Johnson and T. K. Blackwell, “Multiple tristetraprolin sequence domains required to induce apoptosis and modulate responses to TNF$\alpha$ through distinct pathways,” Oncogene, vol. 21, no. 27, pp. 4237–4246, 2002. View at Publisher · View at Google Scholar · View at PubMed
103. N. Schiavone, P. Rosini, A. Quattrone, et al., “A conserved AU-rich element in the $3^{\prime }$ untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis,” The FASEB Journal, vol. 14, no. 1, pp. 174–184, 2000.
104. G. Stoecklin, B. Gross, X.-F. Ming, and C. Moroni, “A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA,” Oncogene, vol. 22, no. 23, pp. 3554–3561, 2003. View at Publisher · View at Google Scholar · View at PubMed
105. B. Li, T. Fink, P. Ebbesen, X. D. Liu, and V. Zachar, “Expression of butyrate response factor 1 in HTLV-1-transformed cells and its transactivation by tax protein,” Archives of Virology, vol. 148, no. 9, pp. 1787–1804, 2003. View at Publisher · View at Google Scholar · View at PubMed
106. D. Wegmüller, I. Raineri, B. Gross, E. J. Oakeley, and C. Moroni, “A cassette system to study embryonic stem cell differentiation by inducible RNA interference,” Stem Cells, vol. 25, no. 5, pp. 1178–1185, 2007. View at Publisher · View at Google Scholar · View at PubMed
107. M. C. Abba, H. Sun, K. A. Hawkins, et al., “Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status,” Molecular Cancer Research, vol. 5, no. 9, pp. 881–890, 2007. View at Publisher · View at Google Scholar · View at PubMed
108. P. J. Zindy, A. L'Helgoualc'h, D. Bonnier, et al., “Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis,” Hepatology, vol. 44, no. 5, pp. 1296–1307, 2006. View at Publisher · View at Google Scholar · View at PubMed
109. D. M. Carrick and P. J. Blackshear, “Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines,” Archives of Biochemistry and Biophysics, vol. 462, no. 2, pp. 278–285, 2007. View at Publisher · View at Google Scholar · View at PubMed
110. C. S. Patil, M. Liu, W. Zhao, et al., “Targeting mRNA stability arrests inflammatory bone loss,” Molecular Therapy, vol. 16, no. 10, pp. 1657–1664, 2008. View at Publisher · View at Google Scholar · View at PubMed